An Internet-based Self-help Intervention to Improve Common Mental Health Problems Among Medical Professionals
EMPOWER
E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.) - A Randomized Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
This randomized controlled trial (RCT) aims to evaluate the effectiveness of an internet-based guided self-help intervention developed based on Problem Solving Therapy, a transdiagnostic low-intensity intervention recommended by the World Health Organization, in improving medical professionals' mental health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2022
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 10, 2025
April 1, 2025
2.7 years
March 28, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from baseline depression immediately after the interventions
The outcome will be measured by the Patient Health Questionnaire (PHQ) consisting of 9 questions designed to correspond to the 9 diagnostic criteria for major depressive disorder listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Items are rated from 0 to 3 according to increased frequency of experiencing difficulties in each area covered. Scores are summed and can range from 0 to 27. Score 10 is often recommended as the cut-off score to detect major depressive disorder. Scores of 5, 10, 15, and 20 represent cut-off points for mild, moderate, moderately severe, and severe depression, respectively. The Chinese version has been validated.
immediately after the interventions
Change from baseline depression 1 month after the interventions
The outcome will be measured by the Patient Health Questionnaire (PHQ) consisting of 9 questions designed to correspond to the 9 diagnostic criteria for major depressive disorder listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Items are rated from 0 to 3 according to increased frequency of experiencing difficulties in each area covered. Scores are summed and can range from 0 to 27. Score 10 is often recommended as the cut-off score to detect major depressive disorder. Scores of 5, 10, 15, and 20 represent cut-off points for mild, moderate, moderately severe, and severe depression, respectively. The Chinese version has been validated.
1 month after the interventions
Change from baseline anxiety immediately after the interventions
The outcome will be measured by the Generalized Anxiety Disorder Scale (GAD), which is a 7-item instrument developed to identify likely cases of generalized anxiety disorder in primary care patients. Items are rated for the last two weeks, using a four-point rating scale for duration from 1 ("not at all") to 5 ("nearly every day"). A score of 10 or greater represents a cut point for identifying cases of generalized anxiety disorder, while cut points of 5, 10, 15, and 20 are interpreted as representing mild, moderate, moderately severe, and severe levels of anxiety. The Chinese version has been validated.
Immediately after the interventions
Change from baseline anxiety 1 month after the interventions
The outcome will be measured by the Generalized Anxiety Disorder Scale (GAD), which is a 7-item instrument developed to identify likely cases of generalized anxiety disorder in primary care patients. Items are rated for the last two weeks, using a four-point rating scale for duration from 1 ("not at all") to 5 ("nearly every day"). A score of 10 or greater represents a cut point for identifying cases of generalized anxiety disorder, while cut points of 5, 10, 15, and 20 are interpreted as representing mild, moderate, moderately severe, and severe levels of anxiety. The Chinese version has been validated.
1 month after the interventions
Study Arms (2)
The EMPOWER program
EXPERIMENTALThe intervention group will receive 4 weekly sessions (the EMPOWER program) in addition to the information about mental health, depression, anxiety and available treatment and community resources received by the waitlist control group.
Education materials
ACTIVE COMPARATORThe waitlist control group receive education materials about mental health, depression, anxiety and available treatment and community resources but not the EMPOWER prgoram during the intervention period.
Interventions
The EMPOWER programme aims to help participants acquire problem-solving skills adapted into the context of MPs' workplace and daily life to address their work-related, personal, and interpersonal problems, including self-neglect, work-life imbalance, patient communication problems, as well as stress during emerging public health crises. The session elements include video introduction, metaphors, daily examples, and narrative stories with prototype MP characters depicting the targeted problems to demonstrate how the taught problem-solving skills could be applied in a variety of situations. Brief exercise and homework will be assigned after each session and personalized written feedback will be provided.
The waitlist control receive education materials covering (1) introduction of mental health problems; (2) signs, symptoms, causes, and consequences of anxiety and depression, and (3) treatment approaches and available community resources.
Eligibility Criteria
You may qualify if:
- (1) being a frontline doctor or nurse working in local public settings;
- (2) at least 18 years of age;
- (3) able to read and understand Chinese;
- (4) have access to the Internet; and
- (5) Patient Health Questionnaire (PHQ-9) and/or Generalized Anxiety Disorder (GAD-7) score\>=5, indicating at least mild levels of depression and/or anxiety.
You may not qualify if:
- (1) currently taking psychotropic medication; and
- (2) actively suicidal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
JC School of Public Health and Primary Care, Faculty of Medicine, CUHK
Hong Kong, China, No postal code, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 4, 2025
Study Start
December 20, 2022
Primary Completion
August 31, 2025
Study Completion
March 31, 2026
Last Updated
April 10, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share